Tech Company Financing Transactions

Garuda Therapeutics Funding Round

Aisling Capital, Cormorant Asset Management and Northpond Ventures joined a $62 million Series B funding round for Garuda Therapeutics. The round closed on 2/7/2023.

Transaction Overview

Company Name
Garuda Therapeutics
Announced On
2/7/2023
Transaction Type
Venture Equity
Amount
$62,000,000
Round
Series B
Investors

Aisling Capital (Lead Investor) (Eric Aguiar)

Cormorant Asset Management (Lead Investor)

Northpond Ventures (Lead Investor)

OrbiMed (Lead Investor) (Carl Gordon)

Alexandria Venture Investments

Mass General Brigham Ventures

Sectoral Asset Management

Proceeds Purpose
The company intends to use the funds to further advance the development of its platform for generation of off-the-shelf, self-renewing blood stem cells towards the clinic as potential treatment for patients with hematological diseases, to continue the advancement of its proprietary HSC-derived off-the-shelf, durable immune cell program for treating patients with oncologic disorders, and advance continued development of HLA-matched pluripotent stem cells broadening the eligibility of patients and increasing access to blood and other cellular therapies in regenerative medicine.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Strathmore Rd.
Natick, MA 01760
USA
Phone
Undisclosed
Website
www.garudatx.com
Email Address
[email protected]
Overview
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
Profile
Garuda Therapeutics LinkedIn Company Profile
Social Media
Garuda Therapeutics Company Twitter Account
Company News
Garuda Therapeutics News
Facebook
Garuda Therapeutics on Facebook
YouTube
Garuda Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dhvanit Shah
  Dhvanit Shah LinkedIn Profile  Dhvanit Shah Twitter Account  Dhvanit Shah News  Dhvanit Shah on Facebook
Co-Founder
Sean Morrison
  Sean Morrison LinkedIn Profile  Sean Morrison Twitter Account  Sean Morrison News  Sean Morrison on Facebook
Co-Founder
David Scadden
  David Scadden LinkedIn Profile  David Scadden Twitter Account  David Scadden News  David Scadden on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/7/2023: Jobber venture capital transaction
Next: 2/7/2023: Stratus venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.